ScholarlyCommons
metadata only
IMPROVING CAR-T CELL PERFORMANCE WITH TARGETED DELIVERY OF CYTOKINES AND CYTOKINE SIGNALS
2026
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study Investigating the Safety of CD19 CAR-T Cells in Relapsed/Refractory AML Expressing CD19#290966
- Immunotherapy With E6 T Cell Receptor (TCR) T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions#1045940
- Induction of CD4<sup>+</sup> Regulatory T Cells by TPA in Mice: Contra-suppression by CD8<sup>+</sup>T Cells#70196
- Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease#851290
- Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate Cancer#356464
Record · ID 929225
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive